RxDoctor Payments Data

William Rogenmoser, DO

Physical Medicine & Rehabilitation · Alexandria, LANPI 1902171176

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $210,453 of the $349,760 with a category attached, or 60.2%. Pacira Pharmaceuticals Incorporated accounts for 99.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $151,176 and has fallen 73.4% since, to $40,177 in 2025. Among physical medicine & rehabilitation clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$349,760in general payments, 2019–2025

Across 224 payments — averaging $1561.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$347K
  • Pacira Cryotech Incorporated$2K
  • Amgen$80
  • Stryker$76
  • GE HealthCare$26
  • AbbVie$14

What the payments were for

  • Consulting fees$210,45360%
  • Speaking & faculty fees$120,48734%
  • Travel & lodging$15,9475%
  • Food & beverage$2,8631%
  • Education$100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pacira Pharmaceuticals Incorporated215$347,448
Pacira Cryotech Incorporated1$2,115
Amgen5$80
Stryker1$76
GE HealthCare1$26
AbbVie1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$349,760 in reported general payments places this provider in the 95th percentile of 117 physical medicine & rehabilitation providers in Louisiana.

See all physical medicine & rehabilitation providers in Louisiana

Medicare billing

Part B allowed, 2024
$814,650
Medicare patients
1,350
Services billed
14,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$18,072
Gabapentin1,231$16,427
XareltoRivaroxaban27$14,298
Celecoxib477$7,287
Tizanidine Hcl823$7,042
Pregabalin483$5,409
Methocarbamol114$1,132
Dantrolene Sodium16$986
Baclofen51$870
Meloxicam168$760
Famotidine80$544
Colestipol Hcl20$418
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$372
Potassium Chloride28$293
Sucralfate13$292

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →